Related Experiment Videos

Proteomic analysis of ubiquitin-proteasome effects: insight into the function of eukaryotic initiation factor 5A

Bao-Feng Jin1, Kun He, Hong-Xia Wang

  • 1Institute of Basic Medical Sciences, National Center of Biomedical Analysis, 27 Tai-Ping Road, Beijing 100850, China.

Oncogene
|August 2, 2003
PubMed

Insights

Ubiquitin-proteasome inhibitors trigger apoptosis in leukemic cells by affecting protein levels. Unmodified eukaryotic initiation factor 5A (eIF-5A) accumulation is key to this process.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • The ubiquitin-proteasome (UP) system regulates protein degradation and is implicated in cancer.
  • Understanding UP inhibitor mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the global proteomic changes induced by UP inhibitors in leukemic cells.
  • To elucidate the role of eukaryotic initiation factor 5A (eIF-5A) in UP inhibitor-induced apoptosis.

Main Methods:

  • Proteomic analysis using 2D gel electrophoresis and peptide mass fingerprinting.
  • Investigating protein modifications like hypusination.
  • Utilizing antisense oligodeoxynucleotides and GM-CSF treatments.

Main Results:

  • Identified 39 protein spots affected by UP inhibitors, including 11 novel apoptosis-associated proteins.
  • Observed suppressed hypusine formation and accumulation of unmodified eIF-5A during UP inhibitor-induced apoptosis.
  • Demonstrated that unmodified eIF-5A is regulated by the proteasome and plays a role in apoptosis.

Conclusions:

  • UP inhibitors induce apoptosis through proteomic alterations, notably affecting eIF-5A.
  • eIF-5A hypusination and subcellular localization are linked to UP inhibitor-induced apoptosis.
  • These findings offer insights into the UP system's role in apoptosis and potential therapeutic strategies.

Related Concept Videos